NCT00078910View on ClinicalTrials.gov

Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

August 31, 2003

Study Completion Date

September 30, 2006

Conditions
Prostate Cancer
Interventions
DRUG

exisulind

PROCEDURE

conventional surgery

PROCEDURE

neoadjuvant therapy

Trial Locations (3)

32224

Mayo Clinic - Jacksonville, Jacksonville

55905

Mayo Clinic Cancer Center, Rochester

85259-5499

Mayo Clinic Scottsdale, Scottsdale

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00078910 - Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate Cancer | Biotech Hunter | Biotech Hunter